Sarepta Therapeutics (SRPT) PT Raised to $35 at Baird
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $20.14 +0.15%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 5
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Shaftesbury Capital PLC (SHC:LN) to Hold
- RBC Capital Downgrades LVMH (MC:FP) (LVMUY) to Sector Perform
- Givaudan SA (GIVN:SW) (GVDNY) PT Raised to CHF3,450 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
